EP3303394
Mótefni gegn CTLA-4 og aðferðir til notkunar þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
27.5.2016EP published:
8.4.2020EP application number:
16728509.7
EP translation filed:
26.6.2020Grant published:
15.7.2020EPO information:
European Patent Register
Max expiry date:
26.5.2036
Title:
ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF
Timeline
Today
27.5.2016EP application
8.4.2020EP Publication
26.6.2020Translation submitted
15.7.2020Registration published
Owner
Name:
Agenus Inc.Address:
3 Forbes Road, Lexington, MA 02421, US
Name:
Ludwig Institute for Cancer Research LtdAddress:
Stadelhoferstrasse 22, 8001 Zürich, CH
Name:
Memorial Sloan Kettering Cancer CenterAddress:
1275 York Avenue, New York, NY 10065, US
Inventor
Name:
van DIJK, MarcAddress:
3722ZH Bilthoven, NL
Name:
MUNDT, Cornelia, AnneAddress:
79539 Loerrach, DE
Name:
RITTER, GerdAddress:
New York, NY 10017, US
Name:
SCHAER, DavidAddress:
Mamaroneck, NY 10543, US
Name:
WOLCHOK, Jedd, DavidAddress:
New York, NY 10016, US
Name:
MERGHOUB, TahaAddress:
Jersey City, NJ 07306, US
Name:
SAVITSKY, David, AdamAddress:
Boxford, MA 01921, US
Name:
FINDEIS, Mark, ArthurAddress:
Belmont, MA 02478, US
Name:
WILSON, Nicholas, StuartAddress:
Somerville, MA 02144, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562168391 PDate:
29.5.2015Country:
US
Number:
201562182363 PDate:
19.6.2015Country:
US
Number:
201562190653 PDate:
9.7.2015Country:
US
Number:
201562257202 PDate:
18.11.2015Country:
US
Number:
201662280263 PDate:
19.1.2016Country:
US
Number:
201662292500 PDate:
8.2.2016Country:
US
Number:
201662294558 PDate:
12.2.2016Country:
US
Number:
201662323226 PDate:
15.4.2016Country:
US
Classification
Categories:
C07K 16/28